--- title: "NRC Health | 8-K: FY2026 Q2 Revenue: USD 35.39 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/294106657.md" datetime: "2026-07-28T20:05:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294106657.md) - [en](https://longbridge.com/en/news/294106657.md) - [zh-HK](https://longbridge.com/zh-HK/news/294106657.md) --- # NRC Health | 8-K: FY2026 Q2 Revenue: USD 35.39 M Revenue: As of FY2026 Q2, the actual value is USD 35.39 M. EPS: As of FY2026 Q2, the actual value is USD -0.15. EBIT: As of FY2026 Q2, the actual value is USD -3.218 M. ### Total Recurring Contract Value (TRCV) NRC Health’s Total Recurring Contract Value (TRCV) was $151.9 million, an increase of 11% year-over-year. ### Revenue Total revenue for the three months ended June 30, 2026, was $35.392 million, up 4% from the prior year’s $34.038 million. For the six months ended June 30, 2026, total revenue was $70.195 million, compared to $67.588 million for the same period in 2025. ### Net Income (Loss) GAAP net loss for the second quarter of 2026 was - $3.283 million, representing -9% of revenue, compared to a net loss of - $0.106 million in the prior year period. For the six months ended June 30, 2026, GAAP net loss was - $0.061 million, a significant decrease from a net income of $5.681 million in the comparable 2025 period.Adjusted Net Income for the second quarter of 2026 was $6.858 million, representing 19% of revenue, up from $6.395 million in the second quarter of 2025. For the six months ended June 30, 2026, Adjusted Net Income was $11.428 million, down from $12.310 million in the same period of 2025. ### Operating Profit / Loss Operating loss for the three months ended June 30, 2026, was - $3.238 million, a decrease from an operating income of $1.588 million in the prior year. For the six months ended June 30, 2026, operating income was $2.331 million, a substantial decrease from $10.184 million in the same period of 2025. ### Operating Costs Total operating expenses for the second quarter of 2026 were $38.630 million, up from $32.450 million in the second quarter of 2025. This included direct costs of $13.564 million (up from $12.974 million), selling, general, and administrative expenses of $22.945 million (up from $17.734 million), and depreciation and amortization of $2.121 million (up from $1.742 million). For the six months ended June 30, 2026, total operating expenses were $67.864 million, compared to $57.404 million in the prior year period. ### Adjusted EBITDA Adjusted EBITDA for the second quarter of 2026 was $9.436 million, representing 27% of revenue, down from $10.302 million (30% of revenue) in the second quarter of 2025. For the six months ended June 30, 2026, Adjusted EBITDA was $18.847 million (27% of revenue), compared to $20.637 million (31% of revenue) in the same period of 2025. ### Cash Flow Net cash flow from operating activities for the second quarter of 2026 was $1.386 million, representing 4% of revenue, a significant improvement from net cash used in operating activities of - $1.139 million in the prior year period. This reflected a cash payment of approximately $2.9 million related to adjustment items. For the six months ended June 30, 2026, net cash provided by operating activities was $8.566 million, up from $5.507 million in the comparable 2025 period.Free cash flow for the second quarter of 2026 was $0.062 million, a substantial improvement from - $4.149 million in the second quarter of 2025. For the six months ended June 30, 2026, Free Cash Flow was $5.408 million, compared to - $0.489 million in the same period of 2025. ### Dividend The Board of Directors declared a quarterly cash dividend of $0.16 per share on July 15, 2026, payable on October 9, 2026, to shareholders of record as of September 25, 2026. ### Outlook NRC Health’s CEO stated that the second quarter results, including double-digit TRCV growth and strong bookings performance for The Governance Institute, positioned the company well for a strong second half of 2026. The company anticipates continued success as healthcare organizations seek partners to improve experience outcomes, strengthen governance, and build brand value. ### Related Stocks - [NRC.US](https://longbridge.com/en/quote/NRC.US.md) ## Related News & Research - [NRC Health CFO Shane Harrison mundur, efektif 28 Agustus 2026](https://longbridge.com/en/news/295577176.md) - [Wall Street Zen Downgrades National Research (NASDAQ:NRC) to Hold](https://longbridge.com/en/news/295992535.md) - [REG - UIL Limited UIL Finance Ltd - Purchase of 2026 ZDP Shares](https://longbridge.com/en/news/295955673.md) - [Can Gold Make a New High in 2026?](https://longbridge.com/en/news/295569739.md) - [Eidesvik Offshore to present Q2 2026 results in digital briefing](https://longbridge.com/en/news/295931470.md)